Changed eating patterns due to the rising use of anti-obesity drugs originally developed to treat diabetes may benefit red ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of cance ...

While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health ...

This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...

Weight-loss drugs have been rolled out by the NHS, but many are buying them through social media and online pharmacies ...

Interestingly, celebrities like Elon Musk, Oprah Winfrey and Amy Schumer, among others, have also endorsed drugs like Ozempic ...

The 15 drugs selected for negotiation are prescribed to 5.3 million Medicare beneficiaries to treat conditions ranging from cancer and type 2 diabetes to asthma.

Obesity medications promise transformative care, but financial and systemic barriers limit access for those most in need.

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

Anti-obesity medication: these are the surprising effects of taking Ozempic and Mounjaro - As weight loss jabs becomes ...

The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...